-
Accelus' new spinal fusion device tops 150 implants
Accelus has announced the first spinal surgeries using its minimally invasive TiHawk11 Interbody Fusion System. -
Globus Medical vs. Smith+Nephew vs. ZimVie: How they compare in Q2
Globus Medical, Smith+Nephew and ZimVie shared their second-quarter results. Of those three companies, one reported a year-over-year increase in revenue. -
Stryker vs. Johnson & Johnson vs. Zimmer Biomet: How they compare in Q2
Stryker, Johnson & Johnson and Zimmer Biomet all saw year-over-year total revenue increases during the second quarter, but their spine and orthopedic sales varied in growth. -
Former Johnson and Johnson, DePuy Spine executive joins Sure Retractors' board of directors
Max Reinhardt has been elected to the board of directors at Sure Retractors, a medical device company specializing in spinal surgery solutions. -
ZimVie reports $8.7M net loss in Q2, expects 2022 revenue of less than $1B
ZimVie on Aug. 10 reported net sales of $233.4 million in the second quarter. -
NuVasive leader to step down, Stryker's Ireland facility and more: 6 device company notes
AxioMed's artificial disc nears FDA approval and five more key updates from spine devicemakers since Aug. 3: -
7 artificial intelligence updates this year
From robotic joint replacements to predicting pain outcomes, artificial intelligence is being used in a variety of ways in orthopedics. -
Surgalign aims to have Holo Portal system in 10-15 sites by 2023
Surgalign's artificial intelligence and augmented reality surgical guidance system, Holo Portal, debuted in the second quarter, and the devicemaker plans to grow its footprint by 2023. -
Surgalign sees Q2, half-year revenue dip
Spine devicemaker Surgalign reported year-over-year revenue decreases in the second quarter and the first half of 2022, according to results posted Aug. 9. -
NuVasive exec to exit
NuVasive's executive vice president and chief commercial officer, Massimo Calafiore, is stepping down, the devicemaker said Aug. 9. -
AxioMed nears FDA approval for total disc implant; surgeon training to start in 2023
AxioMed completed the final steps toward FDA approval for its lumbar viscoelastic disc replacement device. -
Alphatec's Q2 sales soar 35%: 4 notes
Alphatec posted significant year-over-year second-quarter growth and an increase in its surgeon user base, according to results posted Aug. 4. -
Orthofix sees slight dip in Q2 revenue: 4 notes
Orthofix's second-quarter revenue fell compared to the same time last year across most of its business segments, according to results posted Aug. 5. -
3 recent spine devicemaker settlements
Becker's Spine Review has reported on three spine medtech companies settling disputes and conflicts since July 5. -
Spineology single-tube endoscopic system gets limited release
Spineology's OptiLIF Endo system was released in a limited launch, the devicemaker said Aug. 4. -
SpineNet names Bill McDonald COO
Devicemaker SpineNet named Bill McDonald the company's new COO. -
New Stryker 3D printing facility in Ireland could create 600 jobs
Stryker on Aug. 3 opened a 156,000-square-foot additive manufacturing facility in Cork, Ireland, with the capacity to create 600 high-tech positions, according to the country's Industrial Development Agency. -
NuVasive's Q2 revenue rises 5.3%: 4 notes
NuVasive saw year-over-year increase in second-quarter revenue with $310.5 million, according to financial results posted Aug. 3. -
Surgalign reaches $2M settlement with SEC over misreported revenue
Surgalign reached a $2 million settlement with the U.S. Securities and Exchange Commission related to activities between 2015 and 2019, the devicemaker said Aug. 3. -
Zimmer Biomet, Smith+Nephew's Q2 results and more: 6 device company notes
Conmed's multimillion-dollar acquisition and five more updates from spine and orthopedic devicemakers since July 27:
Page 37 of 197